{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:17:08Z","timestamp":1790716628858,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pnpbp.2026.111862","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:59:44Z","timestamp":1785283184000},"page":"111862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neurobiological aspects of the ouabain-induced animal model of bipolar disorder: A narrative review"],"prefix":"10.1016","volume":"149","author":[{"given":"Taise","family":"Possamai-Della","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge M.","family":"Aguiar-Geraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciane B.","family":"Ceretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira S.","family":"Valvassori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2026.111862_bb0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jad.2023.04.137","article-title":"Folic acid does not have an anti-manic effect but protect the brain against oxidative stress in an animal model of mania induced by ouabain","volume":"334","author":"Aguiar-Geraldo","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuroscience.2016.05.058","article-title":"Cognitive flexibility impairment and reduced frontal cortex BDNF expression in the ouabain model of mania","volume":"345","author":"Amodeo","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0015","article-title":"Genistein exerts neuroprotective effects in an ouabain-induced model of bipolar disorder: Behavioral and molecular insights","volume":"51","author":"Arafat","year":"2025","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1734-1140(11)70399-1","article-title":"Magnesium sulfate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal model of mania","volume":"63","author":"Barbosa","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0025","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.neuropharm.2012.01.015","article-title":"Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments","volume":"62","author":"Bartzokis","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2012.00013","article-title":"A pivotal role of GSK-3 in synaptic plasticity","volume":"5","author":"Bradley","year":"2012","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0040","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.neuron.2014.04.003","article-title":"Calcium-dependent PKC isoforms have specialized roles in short-term synaptic plasticity","volume":"82","author":"Chu","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0045","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/10799893.2022.2032747","article-title":"GLP-1 agonist liraglutide improves ouabain-induced mania and depressive state via GSK-3\u03b2 pathway","volume":"42","author":"\u00c7i\u00e7ekli","year":"2022","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0050","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.3390\/ijms130910697","article-title":"Cell signaling through protein kinase C oxidation and activation","volume":"13","author":"Cosentino-Gomes","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpsychires.2019.03.020","article-title":"Tamoxifen has an anti-manic effect but not protect the brain against oxidative stress in an animal model of mania induced by ouabain","volume":"113","author":"Dal-Pont","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0060","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s12035-018-1226-2","article-title":"Inhibition of GSK-3\u03b2 on Behavioral changes and oxidative stress in an animal model of mania","volume":"56","author":"Dal-Pont","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0065","doi-asserted-by":"crossref","first-page":"469???490","DOI":"10.1097\/00008877-199000160-00001","article-title":"Animal models with construct validity for schizophrenia","volume":"1","author":"Ellenbroek","year":"1990","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1176\/jnp.5.4.361","article-title":"Is the Na(+)-K(+)-ATPase the link between phosphoinositide metabolism and bipolar disorder?","volume":"5","author":"El-Mallakh","year":"1993","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-3223(94)00201-D","article-title":"The Na,K-ATPase hypothesis for bipolar illness","volume":"37","author":"El-Mallakh","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0080","article-title":"No NLRP3 inflammasome expression in the ouabain animal model of bipolar disorder","volume":"14","author":"Farooqui","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0085","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1139\/jpn.0637","article-title":"Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania","volume":"31","author":"Frey","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.73","article-title":"Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor \u03b2-arrestin interactions","volume":"3","author":"Gao","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0924-977X(95)00023-I","article-title":"Sleep deprivation in the rat: an animal model of mania","volume":"5","author":"Gessa","year":"1995","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111862_bb0100","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.biopsych.2008.10.033","article-title":"Association between sodium- and potassium-activated adenosine triphosphatase alpha isoforms and bipolar disorders","volume":"65","author":"Goldstein","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jbior.2017.06.003","article-title":"GSK3 and its interactions with the PI3K\/AKT\/mTOR signalling network","volume":"65","author":"Hermida","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.bi.58.070189.000335","article-title":"The protein kinase C family: heterogeneity and its implications","volume":"58","author":"Kikkawa","year":"1989","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0115","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/10799893.2021.1955928","article-title":"Role of TRPV1 channels on glycogen synthase kinase-3\u03b2 and oxidative stress in ouabain-induced bipolar disease","volume":"42","author":"Kukula","year":"2022","journal-title":"J. Recept. Signal Transduction"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0120","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/npp.2010.105","article-title":"Is glycogen synthase kinase-3 a central modulator in mood regulation?","volume":"35","author":"Li","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00768847","article-title":"Na,K-ATPase: isoform structure, function, and expression","volume":"24","author":"Lingrel","year":"1992","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52058-z","article-title":"Intracerebroventricular injection of ouabain causes mania-like behavior in mice through D2 receptor activation","volume":"9","author":"Lopachev","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pbb.2014.11.014","article-title":"Histone deacetylase inhibitors reverse manic-like behaviors and protect the rat brain from energetic metabolic alterations induced by ouabain","volume":"128","author":"Lopes-Borges","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1228455","article-title":"Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder","volume":"17","author":"Machado-Vieira","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105919","article-title":"Previous strength training attenuates ouabain-induced bipolar disorder-related behaviors and memory deficits in rats: involvement of hippocampal ERK\/CREB and PI3K\/AKT\/mTOR pathways","volume":"183","author":"Maidana","year":"2025","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111862_bb0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8","article-title":"Distribution of protein kinase Mzeta and the complete protein kinase C isoform family in rat brain","volume":"426","author":"Naik","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0155","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10409238.2018.1442408","article-title":"Protein kinase C: perfectly balanced","volume":"53","author":"Newton","year":"2018","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00232-021-00207-9","article-title":"Na\/K-ATPase ion transport and receptor-mediated Signaling pathways","volume":"254","author":"Pierre","year":"2021","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0165","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1007\/s12035-022-03022-y","article-title":"Imipramine can be effective on depressive-like Behaviors, but not on neurotrophic factor levels in an animal model for bipolar disorder induced by ouabain","volume":"59","author":"Possamai-Della","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrm2847","article-title":"PKC and the control of localized signal dynamics","volume":"11","author":"Rosse","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0175","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","article-title":"Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: An mechanistic approach","volume":"18","author":"Singh","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14060554","article-title":"Protein kinase C (PKC) in neurological health: implications for Alzheimer's disease and chronic alcohol consumption","volume":"14","author":"Singh","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0185","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbrc.2005.10.194","article-title":"PKC\u03b1 reduces the lipid kinase activity of the p110\u03b1\/p85\u03b1 PI3K through the phosphorylation of the catalytic subunit","volume":"339","author":"Sipeki","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0190","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neulet.2017.04.030","article-title":"Evaluation of se-phenyl-thiazolidine-4-carboselenoate protective activity against oxidative and behavioral stress in the maniac model induced by ouabain in male rats","volume":"651","author":"Sousa","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0195","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbr.2014.06.030","article-title":"The protective effect of melatonin against brain oxidative stress and hyperlocomotion in a rat model of mania induced by ouabain","volume":"271","author":"Souza","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2025.174115","article-title":"Creatine prevents ouabain-induced manic-like behavior by modulating GSK-3\u03b2 via PI3K\/AKT\/mTOR pathway","volume":"257","author":"Souza-Pereira","year":"2025","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0205","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/carcin\/16.10.2589","article-title":"Spectroscopic characterization of specific phorbol ester binding to PKC-receptor sites in membranes in situ","volume":"16","author":"Svetek","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0210","doi-asserted-by":"crossref","first-page":"33753","DOI":"10.1074\/jbc.M303313200","article-title":"Protein kinase C promotes apoptosis in LNCaP prostate Cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway","volume":"278","author":"Tanaka","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0220","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jneuroim.2014.09.007","article-title":"Effects of ouabain on cytokine\/chemokine levels in an animal model of mania","volume":"276","author":"Tonin","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0225","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12035-014-8873-8","article-title":"Intracerebral administration of BDNF protects rat brain against oxidative stress induced by ouabain in an animal model of mania","volume":"52","author":"Valvassori","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0230","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.psychres.2015.11.017","article-title":"Sodium butyrate has an antimanic effect and protects the brain against oxidative stress in an animal model of mania induced by ouabain","volume":"235","author":"Valvassori","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpsychires.2015.04.009","volume":"65","author":"Valvassori","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuropharm.2016.10.015","article-title":"Lithium and valproate act on the GSK-3\u03b2 signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain","volume":"117","author":"Valvassori","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0245","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/ijnp\/pyx049","article-title":"Lithium and tamoxifen modulate behavior and protein kinase C activity in the animal model of mania induced by ouabain","volume":"20","author":"Valvassori","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0494-6","article-title":"Validation of the animal model of bipolar disorder induced by ouabain: face, construct and predictive perspectives","volume":"9","author":"Valvassori","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0255","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jad.2020.12.190","article-title":"Ouabain induces memory impairment and alter the BDNF signaling pathway in an animal model of bipolar disorder: cognitive and neurochemical alterations in BD model","volume":"282","author":"Valvassori","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173434","article-title":"Depressive-like behavior accompanies neuroinflammation in an animal model of bipolar disorder symptoms induced by ouabain","volume":"219","author":"Valvassori","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0265","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jad.2021.12.021","article-title":"Imipramine induces hyperactivity in rats pretreated with ouabain: implications to the mania switch induced by antidepressants","volume":"299","author":"Valvassori","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0270","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpsychires.2014.11.003","article-title":"Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats","volume":"61","author":"Varela","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172917","article-title":"HDAC inhibitors reverse mania-like behavior and modulate epigenetic regulatory enzymes in an animal model of mania induced by ouabain","volume":"193","author":"Varela","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0280","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.psychres.2018.07.031","article-title":"Motor function in an animal model with ouabain-induced bipolar disorder and comorbid anxiety behavior","volume":"268","author":"Wang","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2026.111862_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115923","article-title":"New insights into glycogen synthase kinase-3: a common target for neurodegenerative diseases","volume":"218","author":"Wang","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111862_bb0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12974-024-03054-2","article-title":"Inhibition of MMP8 effectively alleviates manic-like behavior and reduces neuroinflammation by modulating astrocytic CEBPD","volume":"21","author":"Wang","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0295","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41386-025-02076-5","article-title":"The crosstalk between CREB and PER2 mediates the transition between mania- and depression-like behavior","volume":"50","author":"Wang","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2026.111862_bb0300","article-title":"Effects of aspirin in rats with ouabain intracerebral treatment-possible involvement of inflammatory modulation?","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Psychol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626002605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626002605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:37:21Z","timestamp":1790714241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626002605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":60,"alternative-id":["S0278584626002605"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111862","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurobiological aspects of the ouabain-induced animal model of bipolar disorder: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111862"}}